Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma
AimsTo perform a cost-effectiveness analysis (CEA) comparing personalised dosimetry with standard dosimetry in the context of selective internal radiation therapy (SIRT) with TheraSphere for the management of adult patients with locally advanced hepatocellular carcinoma (HCC) from the Italian Health...
Main Authors: | Carla Rognoni, Maria Rosa Barcellona, Irene Bargellini, Maria Grazia Bavetta, Marilena Bellò, Maurizia Brunetto, Patrizia Carucci, Roberto Cioni, Laura Crocetti, Fabio D’Amato, Mario D’Amico, Simona Deagostini, Désirée Deandreis, Paolo De Simone, Andrea Doriguzzi, Monica Finessi, Paolo Fonio, Serena Grimaldi, Salvatore Ialuna, Fabio Lagattuta, Gianluca Masi, Antonio Moreci, Daniele Scalisi, Roberto Virdone, Rosanna Tarricone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.920073/full |
Similar Items
-
Radioembolization for hepatocellular carcinoma using TheraSphere®
by: Safiyya Mohamed Ali
Published: (2011-01-01) -
Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design
by: Etienne Garin, et al.
Published: (2020-06-01) -
Comparison of the Biograph Vision and Biograph mCT for quantitative 90Y PET/CT imaging for radioembolisation
by: Britt Kunnen, et al.
Published: (2020-03-01) -
Applications of Yttrium-90 (90Y) in Hepatocellular Carcinoma
by: Jiang Z, et al.
Published: (2024-02-01) -
Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parameters
by: Yaser H. Gholami, et al.
Published: (2022-07-01)